greeksoup/ stock research

Lumexa Imaging Holdings (LMRI) Q2 FY2025 earnings: revenue $251 million

Lumexa Imaging Holdings, Inc. (LMRI) reported revenue of $251 million for Q2 FY2025, the quarter ended 30 June 2025. Net income was -$7 million, and diluted earnings per share $-0.10. The figures are the company's own, from the 10-Q it filed with the SEC on 13 August 2026.

Revenue$251 million
Net income-$7 million
Diluted EPS$-0.10
QuarterQ2 FY2025ended 30 June 2025

The quarter, against the one before and a year earlier

LineQ2 FY2025Q1 FY2025A year earlierChange on the year
Revenue251245n/an/a
Operating income27.725.5n/an/a
Operating margin11.0%10.4%n/a
Interest expense30.129.8n/an/a
Pre-tax income-2.4-4.3n/an/a
Income tax4.83.4n/an/a
Net income-7.2-7.7n/an/a
Net margin-2.9%-3.1%n/a
Diluted EPS-$0.10-$0.11n/an/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2025Q1 FY2025A year earlierChange on the year
Operating cash flow2.1-14.0n/an/a
Capital expenditure4.61.0n/an/a
Free cash flow-2.5-15.0n/an/a
Free cash flow margin-1.0%-6.1%n/a
Cash from investing-4.2-0.7n/an/a
Cash from financing-0.5-4.1n/an/a
Depreciation and amortisation9.39.1n/an/a
Share-based compensation8.36.4n/an/a
Diluted shares, weighted70m70mn/an/a
Shares outstanding at period end96m96mn/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2025Q1 FY2025A year earlierChange on the year
Shareholders' equity162161n/an/a
Cash and equivalents4.77.3n/an/a

Questions

What was Lumexa Imaging Holdings' revenue in Q2 FY2025?

Lumexa Imaging Holdings (LMRI) reported revenue of $251 million for Q2 FY2025, the quarter ended 30 June 2025.

How much did Lumexa Imaging Holdings earn in Q2 FY2025?

Net loss for Q2 FY2025 was $7 million, and the diluted loss per share $0.10.

When did Lumexa Imaging Holdings report Q2 FY2025 results?

Lumexa Imaging Holdings filed its 10-Q for the quarter ended 30 June 2025 with the SEC on 13 August 2026.

Quarterly results, the last 4 quarters

Q1 FY2025Q2 FY2025Q1 FY2026Q2 FY2026
Revenue245251253264
Operating income25.527.719.423.0
Operating margin10%11%8%9%
Interest expense29.830.116.316.2
Pre-tax income-4.3-2.43.15.8
Tax raten/an/a44%52%
Net income-7.7-7.21.72.7
Net margin-3%-3%1%1%
Diluted EPS-$0.11-$0.10$0.02$0.03
Operating cash flow-14.02.12.932.8
Capital expenditure1.04.65.39.7
Free cash flow-15.0-2.5-2.423.1
Shares outstanding96m96m96m96m
Filing10-Q10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read moreMoney is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 June 2025, filed 13 August 2026: the filing.